Showing results (971-980 of 1,075) with videos related to
Sort By:
Pageof 108
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2001
Value of high-dose cytarabine during interval therapy of a Berlin-Frankfurt-Munster-based protocol in increased-risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma: results of the European Organization for Research and Treatment of Cancer 58881 randomized phase III trialF Millot, S Suciu, N Philippe, et al.Cancer Research|August 24, 2018
Epigenetic Reprogramming with Antisense Oligonucleotides Enhances the Effectiveness of Androgen Receptor Inhibition in Castration-Resistant Prostate CancerLanbo Xiao, Jean C Tien, Josh Vo, et al.The New Phytologist|November 14, 2022
Optimal stomatal theory predicts CO2 responses of stomatal conductance in both gymnosperm and angiosperm treesAnna Gardner, Mingkai Jiang, David S Ellsworth, et al.Bioorganic & Medicinal Chemistry Letters|May 23, 2006
Substituted N-(2-aminophenyl)-benzamides, (E)-N-(2-aminophenyl)-acrylamides and their analogues: novel classes of histone deacetylase inhibitorsOscar Moradei, Silvana Leit, Nancy Zhou, et al.Leukemia|March 4, 2005
Value of intravenous 6-mercaptopurine during continuation treatment in childhood acute lymphoblastic leukemia and non-Hodgkin's lymphoma: final results of a randomized phase III trial (58881) of the EORTC CLGJ van der Werff Ten Bosch, S Suciu, A Thyss, et al.Molecular Cancer|October 12, 2019
LncRNA PVT1 up-regulation is a poor prognosticator and serves as a therapeutic target in esophageal adenocarcinomaYan Xu, Yuan Li, Jiankang Jin, et al.Molecular Cancer Therapeutics|April 17, 2008
MGCD0103, a novel isotype-selective histone deacetylase inhibitor, has broad spectrum antitumor activity in vitro and in vivoMarielle Fournel, Claire Bonfils, Yu Hou, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 18, 2016
Plasmin Prevents Dystrophic Calcification After Muscle InjuryNicholas A Mignemi, Masato Yuasa, Courtney E Baker, et al.Journal of Medicinal Chemistry|June 24, 2008
Discovery of N-(2-aminophenyl)-4-[(4-pyridin-3-ylpyrimidin-2-ylamino)methyl]benzamide (MGCD0103), an orally active histone deacetylase inhibitorNancy Zhou, Oscar Moradei, Stephane Raeppel, et al.RSC Advances|July 18, 2024
Dansyl fluorophore functionalized hierarchically structured mesoporous silica nanoparticles as novel latent fingerprint development agentsLais F A M Oliveira, Lais V A T da Silva, Artur F Sonsin, et al.Pageof 108